Nicotine promotes the development of non-small cell lung cancer through activating LINC00460 and PI3K/Akt signaling
- PMID: 31123168
- PMCID: PMC6554215
- DOI: 10.1042/BSR20182443
Nicotine promotes the development of non-small cell lung cancer through activating LINC00460 and PI3K/Akt signaling
Abstract
Objective: Nicotine, the main ingredient in tobacco, is identified to facilitate tumorigenesis and accelerate metastasis in tumor. Studies in recent years have reported that long intergenic non-protein coding RNA 460 (LINC00460) is strongly associated with lung cancer poor prognosis and nicotine dependence. Nonetheless, it is unclear whether nicotine promotes the development of lung cancer through activation of LINC00460. Methods: We determined that LINC00460 expression in lung cancer tissues and the prognosis in patients with non-small cell lung carcinoma (NSCLC) using Gene Expression Profiling Interactive Analysis (GEPIA) website and The Cancer Genome Atlas (TCGA) database. Through in vitro experiments, we studied the effects of nicotine on LINC00460 in NSCLC cells lines using Cell Counting Kit-8 (CCK-8), transwell test, flow cytometry, quantitative reverse-transcription polymerase chain reaction (qRT-PCR) and Western blot assays. Results: We identified the significant up-regulated expression level of LINC00460 in NSCLC tissues and cell lines, especially, the negative correlation of LINC00460 expression level with overall survival (OS). In in vitro experiments, LINC00460 was overexpressed in NSCLC cell lines under nicotine stimulation. Nicotine could relieve the effect of LINC00460 knockdown on NSCLC cell proliferation, migration and apoptosis. The same influence was observed on PI3K/Akt signaling pathway. Conclusions: In summary, this is the first time to examine the potential roles of LINC00460 in lung cancer cell proliferation, migration and apoptosis induced by nicotine. This may help to develop novel therapeutic strategies for the prevention and treatment of metastatic tumors from cigarette smoke-caused lung cancer by blocking the nicotine-activated LINC00460 pathway.
Keywords: LINC00460; apoptosis; cell migration; nicotine; non-small cell lung cancer; proliferation.
© 2019 The Author(s).
Conflict of interest statement
The authors declare that there are no competing interests associated with the manuscript.
Figures







Similar articles
-
Effects of Linc00460 on cell migration and invasion through regulating epithelial-mesenchymal transition (EMT) in non-small cell lung cancer.Eur Rev Med Pharmacol Sci. 2018 Feb;22(4):1003-1010. doi: 10.26355/eurrev_201802_14382. Eur Rev Med Pharmacol Sci. 2018. PMID: 29509248
-
LINC00460 promotes proliferation and inhibits apoptosis of non-small cell lung cancer cells through targeted regulation of miR-539.Eur Rev Med Pharmacol Sci. 2020 Jun;24(12):6752-6758. doi: 10.26355/eurrev_202006_21663. Eur Rev Med Pharmacol Sci. 2020. PMID: 32633366
-
LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):1093-1101. doi: 10.26355/eurrev_201902_16999. Eur Rev Med Pharmacol Sci. 2019. PMID: 30779077
-
Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.Cell Physiol Biochem. 2017;42(4):1431-1446. doi: 10.1159/000479207. Epub 2017 Jul 17. Cell Physiol Biochem. 2017. PMID: 28715819
-
Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.Tumour Biol. 2017 May;39(5):1010428317697568. doi: 10.1177/1010428317697568. Tumour Biol. 2017. PMID: 28459375
Cited by
-
Construction and validation of a prognostic signature based on anoikis-related lncRNAs in lung adenocarcinoma.Aging (Albany NY). 2024 Jun 7;16(11):9899-9917. doi: 10.18632/aging.205905. Epub 2024 Jun 7. Aging (Albany NY). 2024. PMID: 38850527 Free PMC article.
-
Long non-coding RNA receptor activator of nuclear factor-κ B ligand promotes cisplatin resistance in non-small cell lung cancer cells.Exp Ther Med. 2021 May;21(5):518. doi: 10.3892/etm.2021.9949. Epub 2021 Mar 22. Exp Ther Med. 2021. Retraction in: Exp Ther Med. 2024 May 01;28(1):272. doi: 10.3892/etm.2024.12560. PMID: 33815591 Free PMC article. Retracted.
-
Deciphering Nicotine-Driven Oncogenesis in Head and Neck Cancer: Integrative Transcriptomics and Drug Repurposing Insights.Cancers (Basel). 2025 Apr 24;17(9):1430. doi: 10.3390/cancers17091430. Cancers (Basel). 2025. PMID: 40361356 Free PMC article.
-
Insights into the Mechanisms of Action of Proanthocyanidins and Anthocyanins in the Treatment of Nicotine-Induced Non-Small Cell Lung Cancer.Int J Mol Sci. 2022 Jul 18;23(14):7905. doi: 10.3390/ijms23147905. Int J Mol Sci. 2022. PMID: 35887251 Free PMC article. Review.
-
Using ncRNAs as Tools in Cancer Diagnosis and Treatment-The Way towards Personalized Medicine to Improve Patients' Health.Int J Mol Sci. 2022 Aug 19;23(16):9353. doi: 10.3390/ijms23169353. Int J Mol Sci. 2022. PMID: 36012617 Free PMC article. Review.
References
-
- Du X., Qi F., Lu S., Li Y. and Han W. (2018) Nicotine upregulates Fgfr3 and Rb1 expression and promotes non-small cell lung cancer cell proliferation and epithelial-to-mesenchymal transition via downregulation of mir-99b and mir-192. Biomed. Pharmacother. 101, 656–66210.1016/j.biopha.2018.02.113 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources